Diallyl Disul fi de ( DADS ) , a Constituent of Garlic , Inactivates NFk B and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3 b

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional components and medicinal properties of food: a review

  2015cited by this paper
• Orally administered allyl sulfides from garlic ameliorate murine colitis.

  2015cited by this paper
• Berberine regulates AMP‐activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• Diet-based strategies for cancer chemoprevention: the role of combination regimens using dietary bioactive components.

  2015cited by this paper
• The role of inflammation in colon cancer.

  2014cited by this paper
• Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis.

  2014cited by this paper
• The Immunomodulation and Anti-Inflammatory Effects of Garlic Organosulfur Compounds in Cancer Chemoprevention

  2014cited by this paper
• Inflammatory pathways in the early steps of colorectal cancer development.

  2014cited by this paper
• NF-κB in Cellular Senescence and Cancer Treatment

  2014cited by this paper
• Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.

  2014cited by this paper
• Molecular Diagnostics

  2013influential reference
• Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin.

  2013cited by this paper
• The complexity of NF-κB signaling in inflammation and cancer

  2013cited by this paper
• Epigenetic and genetic features of 24 colon cancer cell lines

  2013cited by this paper
• Targeting the NF-κB pathway in cancer therapy.

  2013cited by this paper
• Pathology of rodent models of intestinal cancer: progress report and recommendations.

  2013cited by this paper
• Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.

  2012cited by this paper
• Inhibitory kappa B kinases as targets for pharmacological regulation

  2012cited by this paper
• Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors.

  2012influential reference
• Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.

  2011cited by this paper
• Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

  2010cited by this paper
• Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography.

  2009cited by this paper
• The IκB kinase complex: master regulator of NF-κB signaling

  2008cited by this paper
• NF‐κB in inflammatory bowel disease

  2008cited by this paper
• Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial.

  2007cited by this paper
• Inhibition of GSK‐3β activity attenuates proliferation of human colon cancer cells in rodents

  2007cited by this paper
• NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta.

  2007cited by this paper
• Dose translation from animal to human studies revisited

  2007cited by this paper
• [Inhibitory effect of diallyl disulfide on proliferation of human colon cancer cell line SW480 in nude mice].

  2007cited by this paper
• Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines.

  2007cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• Clarifying the real bioactive constituents of garlic.

  2006cited by this paper
• Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase‐3β

  2006cited by this paper
• Activation of p53-Dependent Apoptosis by Acute Ablation of Glycogen Synthase Kinase-3β in Colorectal Cancer Cells

  2005cited by this paper
• Signaling to NF-kappaB.

  2004cited by this paper
• Glycogen Synthase Kinase-3β Regulates NF-κB1/p105 Stability*

  2003cited by this paper
• A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate

  2003cited by this paper
• Missing pieces in the NF-kappaB puzzle.

  2002cited by this paper
• Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

  2001influential reference
• Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

  2000cited by this paper
• NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.

  1999cited by this paper
• Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium.

  1999cited by this paper
• Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice.

  1996cited by this paper
• Vegetables, fruit, and colon cancer in the Iowa Women's Health Study.

  1994cited by this paper
• Intake of fat, meat, and fiber in relation to risk of colon cancer in men.

  1994cited by this paper
• Growth factor production by human colon carcinoma cell lines.

  1989cited by this paper
• Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer.

  1987cited by this paper
• Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.

  1987cited by this paper
• Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.

  1974cited by this paper

• Garlic bioactive substances and their therapeutic applications for improving human health: a comprehensive review

  2024cites this paper
• Improving the bioavailability and bioactivity of garlic bioactive compounds via nanotechnology

  2021cites this paper